Home
Products
Hastatoside
| Product Name | Hastatoside |
| Price: | $62 / 10mg |
| Catalog No.: | CN03070 |
| CAS No.: | 50816-24-5 |
| Molecular Formula: | C17H24O11 |
| Molecular Weight: | 404.37 g/mol |
| Purity: | >=98% |
| Type of Compound: | Iridoids |
| Physical Desc.: | Powder |
| Source: | The herbs of Verbena officinalis L. |
| Solvent: | DMSO, Pyridine, Methanol, Ethanol, etc. |
| SMILES: | OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@@]3([C@H]2[C@@H](C)CC3=O)O)C(=O)OC)[C@@H]([C@H]([C@@H]1O)O)O |
| Contact us | |
|---|---|
| First Name: | |
| Last Name: | |
| E-mail: | |
| Question: | |
| Description | Hastatoside is an iridoid glycoside that is isolated from Verbena officinalis and has a role in promoting sleep[1]. |
| In Vivo | Hastatoside (0.32-0.64 mmol/kg; oral administration; for 9 hours; male rats of the Sprague-Dawley strain) treatment increases the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Hastatoside also increases the delta activity during non-rapid eye movement sleep[1]. Animal Model: Male rats of the Sprague-Dawley strain (8 weeks old; 260-280 g)[1] Dosage: 0.32 mmol/kg, 0.48 mmol/kg, 0.64 mmol/kg Administration: Oral administration; for 9 hours Result: Increased the total time of non-rapid eye movement sleep during a 9-h period, with a lag time of about 3-5 h after the administration at 20. 00 hours (lights-off time). Also increased the delta activity during non-rapid eye movement sleep. |
| Density | 1.6±0.1 g/cm3 |
| Boiling Point | 653.5±55.0 °C at 760 mmHg |
| Flash Point | 234.8±25.0 °C |
| Exact Mass | 404.131866 |
| PSA | 172.21000 |
| LogP | -2.38 |
| Vapour Pressure | 0.0±4.5 mmHg at 25°C |
| Storage condition | 2-8C |